ReviewClinical pharmacology in drug development2020

Stable Isotopically Labeled Intravenous Microdose Pharmacokinetic Trials as a Tool to Assess Absolute Bioavailability: Feasibility and Paradigm to Apply for Protein Kinase Inhibitors in Oncology.

Jeroen Roosendaal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.